Posts tagged with ‘Acute Kidney Injury’

Forbion Portfolio Company, AM-Pharma raises €116m
July 16, 2019
Forbion Portfolio Company, AM-Pharma raises €116m to conduct Pivotal Phase III Trial of recAP in acute kidney injury. Please...
0

XS Investments offer investment products and services to professional investors only.
XS Investments BV is licensed by the AFM and under supervision of AFM and DNB. Disclaimer.
©2024 XS Investments. All rights reserved.

Posts tagged with ‘Acute Kidney Injury’

Forbion Portfolio Company, AM-Pharma raises €116m